Dendreon Corp $1.49

up +0.02


17/9/2014 12:10 PM  |  NASDAQ : DNDN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get DNDN Trend Analysis - it has underperformed the S&P 500 by 68%

Partner Headlines

  1. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD
  2. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus
  3. Morning Market Losers

    Benzinga
  4. Dendreon's Debt Problem: Mulls Wiping Out Shareholders

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. Cantor Weighs In On Dendreon Leadership Change

    Benzinga
  9. Morning Market Losers

    Benzinga
  10. Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats ...

    Benzinga
  11. Dendreon Says Prelim. Data from LT Phase II STAND Study Will Be Presented ...

    Benzinga
  12. Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

    Benzinga
  13. Mid-Afternoon Market Update: Markets Rally on Easing Ukraine Tensions as ...

    Benzinga
  14. Morning Losers for Mar. 4, 2014: RSH, MDR, WBMD, CLF, DNDN

    Benzinga
  15. Benzinga's Top Downgrades

    Benzinga
  16. Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon ...

    Benzinga
  17. Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean ...

    Benzinga
  18. Morning Gainers for Mar. 3, 2014: DNDN, PERI, RVNC, ARRY, OMEX, NIHD

    Benzinga
  19. Morning Market Movers

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. Earnings Scheduled For March 3, 2014

    Benzinga
  22. Mid-Afternoon Market Update: Markets Recovering Towards the End of the ...

    Benzinga
  23. Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

    Benzinga
  24. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  25. Earnings Expectations For The Week Of November 11: Walmart And Other Retailers

    Benzinga
  26. UPDATE: Maxim Upgraded Dendreon, Raises High PT

    Benzinga
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. Benzinga's Weekend M&A Chatter

    Benzinga
  29. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  30. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  31. Dendreon Reports Presentation of PROVENGE® Data at '13 European Cancer ...

    Benzinga
  32. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  33. Dendreon Reports Marketing Authorization for Provenge in EU

    Benzinga
  34. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  35. RBC Sets Likelihoods For Dendreon Sale Possibilities Moving Forward, Cuts ...

    Benzinga
  36. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

    Benzinga
  37. Stocks Hitting 52-Week Lows

    Benzinga
  38. UPDATE: Deutsche Bank Downgrades Dendreon on Approaching Headwinds

    Benzinga
  39. Stocks Hitting 52-Week Lows

    Benzinga
  40. Benzinga's Top Pre-Market Losers

    Benzinga
  41. Benzinga's Top Downgrades

    Benzinga
  42. An Ocean of 52-Week Lows - 50% Off High, Second Quarter Financials

    GuruFocus
  43. Mid-Afternoon Market Update: Markets All Red as Dendreon Continues to Fall

    Benzinga
  44. Mid-Day Market Update: Markets Fall Sharply, Priceline Surges On Earnings ...

    Benzinga
  45. Mid-Morning Market Update: Markets Edge Lower, Lions Gate Reports Q1 Profit

    Benzinga
  46. Benzinga's Top Pre-Market Losers

    Benzinga
  47. Price Target on Dendreon Slashed from $1 to $0 at Wedbush, Says Expecting ...

    Benzinga
  48. Benzinga's Top Pre-Market Gainers

    Benzinga
  49. Mid-Afternoon Market Update: Dendreon Skyrockets as The Markets Trade in ...

    Benzinga
  50. Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

    Benzinga
Trading Center